Quarry LP Sells 473 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Quarry LP cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 34.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 887 shares of the company’s stock after selling 473 shares during the quarter. Quarry LP’s holdings in HCA Healthcare were worth $266,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Prosperity Consulting Group LLC grew its holdings in shares of HCA Healthcare by 1.0% during the fourth quarter. Prosperity Consulting Group LLC now owns 9,231 shares of the company’s stock worth $2,771,000 after buying an additional 93 shares in the last quarter. Oxford Asset Management LLP bought a new position in shares of HCA Healthcare during the fourth quarter worth about $879,000. Boothbay Fund Management LLC bought a new position in shares of HCA Healthcare during the fourth quarter worth about $786,000. Coldstream Capital Management Inc. boosted its position in HCA Healthcare by 1.3% during the fourth quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company’s stock valued at $1,042,000 after purchasing an additional 44 shares during the last quarter. Finally, Hancock Whitney Corp boosted its position in HCA Healthcare by 24.8% during the fourth quarter. Hancock Whitney Corp now owns 5,130 shares of the company’s stock valued at $1,540,000 after purchasing an additional 1,019 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $327.69 on Monday. The stock has a 50 day simple moving average of $329.82 and a 200 day simple moving average of $331.76. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $80.68 billion, a P/E ratio of 14.92, a PEG ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts’ consensus estimates of $5.77 by $0.68. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.36 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.88%. HCA Healthcare’s payout ratio is 12.81%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on HCA shares. Baird R W cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. KeyCorp reduced their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Guggenheim assumed coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a “neutral” rating for the company. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Royal Bank of Canada cut their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $381.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.